CH Basel Balavenkatraman KK: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{MiPNetLab | {{MiPNetLab | ||
|address=Balavenkatraman Kamal Kumar, Dr. | |address=[[Balavenkatraman KK|Balavenkatraman Kamal Kumar]], Dr. | ||
Investigator II (iTox-PCS) | Investigator II (iTox-PCS) - Novartis Pharma Ltd. | ||
Novartis Pharma Ltd. | |||
WKL-135.3.21 | WKL-135.3.21 | ||
| Line 10: | Line 8: | ||
Klybeckstr 191 | Klybeckstr 191 | ||
CH-4057 Basel, Switzerland | CH-4057 Basel, Switzerland | ||
|city=Basel | |city=Basel | ||
|country=Switzerland | |country=Switzerland | ||
|MiPNetLab=Balavenkatraman KK, Grueninger S, Weiss A | |MiPNetLab=Balavenkatraman KK, Grueninger S, Weiss A | ||
|Team previous=Chiesi M | |Team previous=Chiesi M | ||
|info=IOC39 | |info=[http://oroboros.at/index.php?id=ioc39-schroecken IOC39] | ||
|Info=[http://www.oroboros.at/index.php?id=1215 CH_Basel_ChiesiM] | |Info=[http://www.oroboros.at/index.php?id=1215 CH_Basel_ChiesiM] | ||
}} | }} | ||
* Previously CH_Basel_Chiesi M | * Previously CH_Basel_Chiesi M | ||
Revision as of 10:51, 1 August 2012
- Previously CH_Basel_Chiesi M
